Share this article and save a life!
CMS just froze Medicare enrollment for medical equipment suppliers.
Starting yesterday (Feb 27), no new DMEPOS companies can join Medicare for the next 6 months.
Here’s what healthcare leaders need to know:
📊 The numbers are staggering:
• 7 supplier types blocked from enrollment
• 6-month initial freeze, possibly extending longer
• Affects orthotics, prosthetics, respiratory equipment suppliers
• Existing enrolled suppliers keep billing without disruption
Why now? HHS-OIG reports exposed massive DMEPOS fraud schemes. CMS is taking aggressive action to protect Medicare funds and beneficiaries.
The ripple effects will be significant:
• Sleep centers expanding services? Delayed.
• New DME startups? On hold.
• Ownership changes? Blocked if they trigger re-enrollment.
• Competitive bidding for late 2026? Disrupted.
For integrated care models, this creates immediate challenges. Many health systems rely on DME partnerships for home-based care transitions. Without new supplier enrollment, scaling these programs just got harder.
The compliance stakes are high. Any attempts to circumvent this moratorium could trigger 1-10+ year Medicare bans. CMS is conducting site visits and using data analytics to catch violators.
What strikes me most: This impacts underserved communities hardest.
Rural areas already struggle with DME access. A 6-month enrollment freeze could mean patients waiting longer for critical equipment like PAP devices, oxygen supplies, or mobility aids.
Health systems should act now:
✓ Audit existing DME partnerships
✓ Lock in current supplier contracts
✓ Prepare contingency plans for expansions
✓ Monitor state Medicaid programs (they often follow CMS)
This moratorium signals a broader shift in Medicare’s approach to fraud prevention. Expect more aggressive enforcement actions across other provider types.
The message from CMS is clear: Program integrity trumps rapid growth.
For healthcare executives planning 2026 expansions involving DME services, it’s time to recalibrate timelines and strategies.
♻️ Repost if Medicare fraud prevention needs stronger enforcement
👉 Follow me, Jonathan Govette, for daily, real-time updates on healthcare technology and business news. LinkedIn Profile: https://www.linkedin.com/in/jonathangovette/
Share this article and save a life!
Author:
CEO/Co-Founder @ Oatmeal Health | AI Lung Cancer Screening | Almost Became a Doctor | Engineer | Follow to Share What I’ve Learned Along the Way
I help patients get the care they need earlier, preventing late-stage cancer.
That’s been the throughline across three companies and almost 20 years in healthcare. At ReferralMD, we fixed broken referral networks so patients didn’t fall through the cracks. At Oatmeal Health, it’s lung cancer: building the diagnostic and screening infrastructure so the 85% of cases caught too late get caught early instead.
Today as CEO of Oatmeal Health, I lead a team embedding AI into radiology workflows to turn routine lung CT scans into reimbursable cancer risk assessments. We partner with FQHCs to reach underserved communities, and with health systems and payers to make early detection economically sustainable. Think HeartFlow or Cleerly, but for lungs.
Between companies, I advised at Techstars and Plug and Play, mentoring founders building in digital health. That experience shaped how I think about what separates companies that ship from companies that stall: distribution, reimbursement, and clinical trust, not just technology.
I’m a CancerX alumnus, a 3x healthcare founder, and someone who believes the biggest problems in cancer aren’t scientific. They’re operational.
We’re hiring mission-driven builders at Oatmeal Health. If you want to work on something that matters, reach out.
When I’m not working, I’m traveling, mentoring, and keeping up with one very energetic husky. 🐾
Substack – The Oatmeal Bite:
Millions of patients get less care because of who they are, where they live, or how they look. I’m fighting to change that. CEO @OatmealHealth, a startup built for the underserved. The Oatmeal Bite: intel for clinicians, investors, and advocates.
Jonathan Govette
CEO of Oatmeal Health
Substack:
https://oatmealhealthjonathangovette.substack.com/
